RxSight (RXST) Change in Accured Expenses (2020 - 2026)

RxSight (RXST) has reported Change in Accured Expenses for 7 consecutive years, with -$262000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses fell 125.36% year-over-year to -$262000.0; the trailing twelve-month figure through Jun 2026 stood at $1.7 million (down 16.36% YoY), and the FY2025 full-year result was -$1.9 million, down 131.95% from the prior year.
• Change in Accured Expenses advanced to -$262000.0 in Q2 2026 per RXST's latest filing, from -$1.3 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.7 million in Q3 2024 and bottomed at -$6.2 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $533555.6 across 5 years, with a median of $1.5 million in 2023.
• The widest YoY moves for Change in Accured Expenses: up 91.9% in 2022, down 191.16% in 2022.
• Over 5 years, Change in Accured Expenses stood at $2.4 million in 2022, then decreased by 9.52% to $2.2 million in 2023, then surged by 58.72% to $3.5 million in 2024, then slumped by 51.26% to $1.7 million in 2025, then slumped by 115.43% to -$262000.0 in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$262000.0, -$1.3 million, and $1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.